Disrupted sleep patterns in Alzheimer’s disease may be more than a symptom—they could be a driving force. Researchers at ...

A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...

Lupin is releasing an authorized generic version of Horizon Therapeutics’ Ravicti (glycerol phenylbutyrate) oral liquid, 1.1g ...